Skip to content
OpenCapital
Get started

Edwards Lifesciences EW Europe — Net Sales

Other segment segments

United States
$937.6M+11.8%
Rest of World
$177.8M+18.4%
Japan
$90.6M+10.8%

Similar metrics at other companies

Trimas logo
TRSEurope — Net Sales
$37.62M-5.4%
Materion logo
MTRNEurope — Net Sales
$142.65M+32.3%
Perrigo Company logo
PRGOEurope — Net Sales
$391.4M-5.1%
Atkore logo
ATKREurope — Net Sales
$52.82M-7.5%
DCH
DCHEurope — Net Sales
$588.2M+201%
Mativ Holdings logo
MATVEurope — Net Sales
$136.6M+8.6%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%—

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's europe — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's europe — net sales?
Edwards Lifesciences (EW) reported europe — net sales of $442.6M in Q1 2026.
How has Edwards Lifesciences's europe — net sales changed year-over-year?
Edwards Lifesciences's europe — net sales increased by 29.5% year-over-year, from $341.8M to $442.6M.
What is the long-term trend for Edwards Lifesciences's europe — net sales?
Over 4 years (2021 to 2025), Edwards Lifesciences's europe — net sales has grown at a 8.4% compound annual growth rate (CAGR), from $1.1B to $1.52B.
What does europe — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and structural heart technologies within the European geographic market. It reflects the company's market penetration and demand for its product portfolio in this specific region. Tracking this figure helps investors assess the growth trajectory and competitive positioning of the firm's international operations.